pyrazinamide has been researched along with Escherichia coli Infections in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
Excerpt | Relevance | Reference |
---|---|---|
"No other case of spondylodiscitis caused by a mycobacterial coinfection pathogen has been reported so far." | 1.33 | [Cervical spondylodiscitis: one pathogen may hide another]. ( Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Toubiana, J | 1 |
Salomon, J | 1 |
Ader, F | 1 |
Perronne, C | 1 |
Carlier, R | 1 |
Bernard, L | 1 |
1 other study available for pyrazinamide and Escherichia coli Infections
Article | Year |
---|---|
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Disc | 2006 |